Sign In
Buy SOLV
$74.56
-2.00 (-2.61%)
At Close: Jun 17, 2026
SOLV vs. DOCS: Which Stock Is the Better Value Option?
12:45pm, Tuesday, 29'th Apr 2025
Investors looking for stocks in the Medical Services sector might want to consider either Solventum (SOLV) or Doximity (DOCS). But which of these two companies is the best option for those looking for
Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025
04:05pm, Thursday, 17'th Apr 2025
ST. PAUL, Minn. , April 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, after the U.S. financial markets close.
Solventum (SOLV) Soars 8.8%: Is Further Upside Left in the Stock?
12:35pm, Thursday, 10'th Apr 2025
Solventum (SOLV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Tuesday, 08'th Apr 2025
Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Tuesday, 08'th Apr 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Solventum Partners With SprintRay for Same-Day Dental Restorations
12:16pm, Monday, 31'st Mar 2025
SOLV partners with SprintRay to introduce an innovative solution for same-day dental restorations, enhancing efficiency, precision and patient care in digital dentistry.
Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations
06:00pm, Tuesday, 25'th Mar 2025
In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity and durability of permanent same-day restorative dental o
3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy
12:44pm, Friday, 21'st Mar 2025
On Thursday, Solventum SOLV hosted its 2025 Investor Day, during which it outlined its strategic priorities, its business segments, and its long-range plan (LRP) to drive growth and value creation.
Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day
09:00am, Thursday, 20'th Mar 2025
Provides 2028 Targets for Revenue Growth, Margin Expansion, and Free Cash Flow ST. PAUL, Minn.
Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance
08:12am, Wednesday, 12'th Mar 2025
ST. PAUL, Minn. , March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electroni
Billionaire Nelson Peltz Has 67% of His Hedge Fund's $3.9 Billion Portfolio Invested in Just 3 Stocks
09:02am, Saturday, 08'th Mar 2025
2024 was quite a year for Nelson Peltz's hedge fund, Trian Fund Management.
SOLV Stock Down Despite Q4 Earnings & Revenues Beat Estimates
12:35pm, Friday, 28'th Feb 2025
Solventum's fourth-quarter earnings showcase strong segmental performance. However, declining margins raise concerns.
Solventum: Q4 EPS Beats, Cash Flow Dips
09:07am, Friday, 28'th Feb 2025
Diversified healthcare company Solventum (SOLV -0.71%) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at $1
Solventum Corporation (SOLV) Q4 2024 Earnings Call Transcript
08:36am, Friday, 28'th Feb 2025
Solventum Corporation (NYSE:SOLV ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations and External Finance Com
Solventum forecasts annual profit above estimates on strong surgical product sales
05:09pm, Thursday, 27'th Feb 2025
3M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
